Advisory - Unauthorized sexual enhancement products seized at four Toronto retail locations may pose serious health risks

Unauthorized sexual enhancement products (CNW Group/Health Canada)

OTTAWA, Aug. 4, 2017 /CNW/ -

Issue
Health Canada is advising Canadians that multiple unauthorized sexual enhancement products seized from four Toronto retail locations may pose serious risks to health.

Who is affected

• Consumers who have bought or used any of these products.

Affected products
The following unauthorized products were seized as they are labelled to contain the ingredients listed below:

Retailer	Products	Ingredient(s)
The Men's Room 465 Church St. Toronto, ON	Passion Classic	Yohimbe
Hasty Market 557 Church St, Toronto, ON	Hard Rock 3800	Yohimbe bark extract
Yeno Trading 169 The West Mall, Etobicoke, ON	Hard Rock 3800	Yohimbe bark extract
	Premium Pro Power 3500	Yohimbe bark extract
	Premium X Pulse 2000	Yohimbe

The following unauthorized products were also seized by Health Canada. The Department previously seized unauthorized products with similar packaging from other retailers because they were tested and found to contain a prescription drug:

Retailer	Products	Details
Out On The Street 551 Church St. Toronto ON	Blue Diamond	Previously tested product with similar packaging was found to contain sildenafil
	ResErection!	Previously tested product with similar packaging was found to contain sildenafil and tadalafil
The Men's Room 465 Church St. Toronto, ON	ResErection!	Previously tested product with similar packaging was found to contain sildenafil and tadalafil

What consumers should do

• Stop using these products. Consult with your health care professional if you have used any of these products and have health concerns.
• Read product labels to verify that health products have been authorized for sale by Health Canada. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM). You can also check whether products have been authorized for sale by searching Health Canada's Drug Product Database and Licensed Natural Health Product Database.
• Report adverse events to health products to Health Canada by calling toll-free at 1-866-234-2345, or by reporting online, by mail or by fax.
• Report complaints about health products to Health Canada by calling toll-free at 1-800-267-9675, or complete an online complaint form.

What Health Canada is doing
Health Canada seized the unauthorized products from the retail locations. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians as necessary.

Background
Sildenafil and tadalafil are prescription drug ingredients. Products containing these ingredients should be used only under the supervision of a health care practitioner. Sildenafil and tadalafil should not be used by individuals taking any kind of nitrate drug (such as nitroglycerine) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure and abnormal heartbeat. Other side effects include headache, facial flushing, indigestion, dizziness, abnormal vision and hearing loss.

Yohimbine is a prescription drug and should be used only under the supervision of a health care professional. Yohimbine is derived from yohimbe, a bark extract. The use of yohimbine or yohimbe may result in serious adverse reactions, particularly in people with high blood pressure, or heart, kidney or liver disease. Side effects include increased blood pressure and heart rate, anxiety, dizziness, tremors, headache, nausea and sleep disorders. It should not be used by children, or pregnant or nursing women.

Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.

Également disponible en français

SOURCE Health Canada

For further information: Media Enquiries: Health Canada, [phone]; Public Enquiries: [phone], 1-866 225-0709